PHCN and CADTH – Needed: Survey participants with hep C or living with/caring for someone with hep C

Survey participants with hep C or living with/caring for someone with hep C needed immediately!

Take this survey!

The Canadian Agency for Drugs and Technologies in Health (CADTH) is currently seeking patient group input reports for ombitasvir / paritaprevir / ritonavir and dasabuvir, developed by AbbVie. Thus, Pacific Hepatitis C Network (PHCN) needs your help for our report.

The patient group input reports requested by CADTH are an important step towards getting new treatments for hep C more widely available in Canada and BC. You can be a part of this process!

The survey is newly redesigned and includes 33 questions, mostly multiple choice, that are divided into five sections. The sections that don’t pertain to you, such as the section about your experience with ombitasvir / paritaprevir / ritonavir and dasabuvir if you’ve never taken this hep C treatment, can be easily skipped. Those living with/caring for someone with hep C are only asked to complete eight questions.

Survey responses are anonymous (we don’t know your name or other information about you). The information gathered will be used as part of a patient group input report for CADTH. By completing the survey you accept that PHCN can use the information gathered by it in our patient group input report for CADTH.

Thank you for taking the time to voice your opinion and help advocate for a better tomorrow.

Please email [email protected] for more information about the survey or visit PHCN’s Hepatitis C Treatment Information Project for more information about ombitasvir / paritaprevir / ritonavir and dasabuvir and the different hep C treatments within the drug pipeline.

The post Take this survey appeared first on Pacific Hepatitis C Network.